Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities

v3.23.2
Note 8 - Accrued Liabilities
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Accrued liabilities
8.
Accrued liabilities:

Accrued liabilities as of June 30, 2023 and December 31, 2022 consisted of the following:

 

 

 

June 30,

 

 

December 31,

 

 

 

2023

 

 

2022

 

Accrued personnel related costs

 

$

1,645

 

 

$

2,302

 

Accrued research and development expenses

 

 

6,029

 

 

 

3,122

 

Other accrued expenses

 

 

410

 

 

 

233

 

Total

 

$

8,084

 

 

$

5,657